GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (NAS:PROF) » Definitions » Cyclically Adjusted PB Ratio

PROF (Profound Medical) Cyclically Adjusted PB Ratio : 1.60 (As of May. 13, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Profound Medical Cyclically Adjusted PB Ratio?

As of today (2025-05-13), Profound Medical's current share price is $4.28. Profound Medical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $2.68. Profound Medical's Cyclically Adjusted PB Ratio for today is 1.60.

The historical rank and industry rank for Profound Medical's Cyclically Adjusted PB Ratio or its related term are showing as below:

PROF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.66   Med: 2.63   Max: 3.63
Current: 1.66

During the past years, Profound Medical's highest Cyclically Adjusted PB Ratio was 3.63. The lowest was 1.66. And the median was 2.63.

PROF's Cyclically Adjusted PB Ratio is ranked better than
55.35% of 495 companies
in the Medical Devices & Instruments industry
Industry Median: 1.87 vs PROF: 1.66

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Profound Medical's adjusted book value per share data for the three months ended in Dec. 2024 was $2.011. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.68 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Profound Medical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Profound Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical Cyclically Adjusted PB Ratio Chart

Profound Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.80

Profound Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.76 2.68 2.80

Competitive Comparison of Profound Medical's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Profound Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Profound Medical's Cyclically Adjusted PB Ratio falls into.


;
;

Profound Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Profound Medical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.28/2.68
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Profound Medical's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=2.011/127.3637*127.3637
=2.011

Current CPI (Dec. 2024) = 127.3637.

Profound Medical Quarterly Data

Book Value per Share CPI Adj_Book
201503 5.585 99.789 7.128
201506 3.951 100.500 5.007
201509 3.143 100.421 3.986
201512 2.549 99.947 3.248
201603 2.017 101.054 2.542
201606 1.341 102.002 1.674
201609 0.562 101.765 0.703
201612 1.996 101.449 2.506
201703 1.467 102.634 1.820
201706 0.919 103.029 1.136
201709 2.026 103.345 2.497
201712 1.538 103.345 1.895
201803 2.995 105.004 3.633
201806 2.534 105.557 3.057
201809 2.229 105.636 2.687
201812 1.809 105.399 2.186
201903 1.656 106.979 1.972
201906 1.298 107.690 1.535
201909 1.485 107.611 1.758
201912 1.212 107.769 1.432
202003 3.297 107.927 3.891
202006 3.153 108.401 3.705
202009 4.740 108.164 5.581
202012 4.817 108.559 5.651
202103 4.594 110.298 5.305
202106 4.410 111.720 5.028
202109 4.238 112.905 4.781
202112 3.880 113.774 4.343
202203 3.583 117.646 3.879
202206 3.256 120.806 3.433
202209 2.880 120.648 3.040
202212 2.491 120.964 2.623
202303 2.308 122.702 2.396
202306 2.087 124.203 2.140
202309 1.805 125.230 1.836
202312 1.461 125.072 1.488
202403 1.877 126.258 1.893
202406 1.603 127.522 1.601
202409 1.260 127.285 1.261
202412 2.011 127.364 2.011

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Profound Medical  (NAS:PROF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Profound Medical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Profound Medical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Profound Medical Business Description

Traded in Other Exchanges
Address
2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.